Nassereddine(S),Feng(Y),Selep(J),El Chaer(... Ann Hematol 2026-05-09

...ELN 2017 risk classification, and white blood cell count. Among younger patients, DTI was not associated with difference...

Federico(V),Avenoso(D),Raj(K),De Lavallade... Transplant Cell Ther 2026-05-11

...ELN-2017), aged ≥65 years, with haematopoietic cell transplantation-comorbidity index (HCT-CI) ≥2, lacking an HLA-identi...

Zuo(X),Chen(Z),Chen(XQ),Guan(D),Shaw(PX),J... NPJ Parkinsons Dis 2026-05-12

...ELN), yet the molecular mechanisms linking α-synuclein pathology to neuronal dysfunction remain unclear. Here we report ...

Ducourneau(B),Pages(A),Struski(S),Decamp(M... Leukemia 2026-07-00

...ELN adverse patients whether initially classified as intermediate (20.3 months [11.7-30.2]) or adverse (15.7 months [13....

Yaseen(A),Abusalim(E),Harb(M),Sarhan(Z),Ta... Cancers (Basel) 2026-04-22

...ELN) and the 2025 US expert panel recommendations, highlighting important differences in preferred methodologies and dec...

Zhong(J),Liu(X),Gu(X),Liu(Z) Int J Mol Sci 2026-04-22

...ELN/FAB features, increased immune checkpoint expression, enrichment of inflammatory and immunoregulatory pathways, and ...

Yakutovich(AV),Hollas(D),Bainglass(E),Yu(J... Digit Discov 2026-05-20

...ELNs) for FAIR-compliant data management, adoption in large-scale facilities for secure access to experimental data and ...

Kageyama(Y),Namba(K),Akamatsu(Y),Ebisui(T)... Biomed Rep 2026-06-00

...ELNs from T. fruticosum (TfELNs) were isolated and characterized, and their key biological activities were examined. TfE...

Hirao(T),Yamamoto(H),Kuno(M),Watanabe(O),Y... Transplant Cell Ther 2026-05-12

...ELN criteria), AML myelodysplasia-related (AML-MR), postcytotoxic therapy AML, or poor treatment response (primary induc...

Zamora(P),Moncada(Á),Loinaz(I),Dupin(D) Carbohydr Polym 2026-07-01

...ELN expression was increased by 1.69-fold in the dermis. Altogether, EM-NM proved to enhance NM biological activity and ...